A senior NHS Glasgow executive is under fire for allegedly attempting to influence a report on a scandal involving patient infections at a hospital. Professor Mike Stevens, a child cancer specialist, accused NHS Greater Glasgow and Clyde chief executive Jane Grant of trying to manipulate his findings related to a series of infections at the Queen Elizabeth University Hospital (QEUH). The accusations have sparked calls from Scottish Labour for a thorough investigation into the matter.
During a public inquiry into the hospital scandal, Professor Stevens claimed that Jane Grant tried to pressure him into altering his report, which was investigating the connection between patient deaths and infections at the hospital. The inquiry is specifically focusing on the construction of the £842 million superhospital in Glasgow and its potential link to unusual infections affecting patients. Scottish Labour’s deputy leader, Jackie Baillie, expressed concern over the alleged actions of the NHS boss, highlighting a culture of secrecy that could threaten patient safety.
Professor Stevens revealed that after completing his review of 118 infection cases, he received a letter from Jane Grant in March 2021, prompting him to feel pressured to change his conclusions. He suggested that the letter was an attempt to influence the final report in a certain direction. Grant, who is set to retire as the chief executive of NHSGGC, has yet to testify at the ongoing public inquiry. Her successor, Professor Jann Gardner, is scheduled to take over in February 2025.
In response to the allegations, a spokesperson for NHS Greater Glasgow and Clyde stated that they would cooperate fully with the inquiry to establish the facts. The accusations against Jane Grant have raised serious concerns about transparency and accountability within the health board’s leadership.
In summary, the accusations against NHS Glasgow boss Jane Grant for allegedly trying to manipulate a report on patient infections at a hospital have raised concerns about transparency and accountability in the health sector. The ongoing public inquiry into the scandal will shed light on the actions of the health executive and the potential implications for patient care.